新里程：11月4日召开董事会会议

Group 1 - The core point of the article highlights that New Mileage (SZ 002219) held its 36th meeting of the sixth board of directors on November 4, 2025, to discuss the proposal for applying for credit limits from banks [1] - For the first half of 2025, New Mileage's revenue composition shows that the medical industry accounts for 86.85%, while the pharmaceutical industry accounts for 13.15% [1] - As of the report, New Mileage has a market capitalization of 7.7 billion yuan [1] Group 2 - The article reports a significant increase in overseas orders for a certain industry, with a surge of 246%, covering over 50 countries and regions [1] - Entrepreneurs have raised concerns about some companies selling products at a loss, warning of the potential for vicious competition extending to overseas markets [1]